Purchases and Sales Made in Q1 2022 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q1 2022. The information is specifically focused on institutions that hold shares of ARROWHEAD PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-691KClosed |
$27.4M - $48.3M
|
0
$0
|
|
|
May 09, 2022
Q1 2022
|
Johnson & Johnson
New Brunswick, NJ |
SELL
|
- |
-2M- 61.33% |
$79.2M - $140M
|
1.26M
$26.5M
|
|
|
May 16, 2022
Q1 2022
|
Rokos Capital Management LLP
London, X0 |
SELL
|
- |
-2.06M- 99.15% |
$81.5M - $144M
|
17.7K
$372K
|